【24h】

A Disease-Centric Draft Map of the Human Interactome

机译:一种以人类互乱的疾病为中心的草稿地图

获取原文

摘要

Topics: Large-scale human protein interaction map; Statistical framework for estimating coverage (false-negative rate) of sampled networks; A new sequencing machine 179f 1-18 From experimental data to mechanistic hypotheses: analysis of proteomic data using a very large-scale causal model Dexter Pratt Genstruct Inc, One Alewife Center, Cambridge MA 02140 High-throughput proteomic analyses of tissue and bio-fluid samples can yield datasets comprising measured differences in hundreds - or even thousands - of proteins. In principle, this rich source of data can provide a systems-level view of the biological processes in an experiment, leading to testable hypotheses describing the mechanisms that led to the observed changes. But typically, the integration of hundreds of observations to infer the active biological networks is an unmanageable task, limiting the analysis to categorization of the changed proteins by annotations and by patterns of modulation. To identify disease mechanisms, compound mechanisms and biomarkers from proteomic and systems biology experiments requires the development of a model of biology. Using a mental model, a scientist can reason about hundreds of distinct molecules present within a cell, but reasoning over tens of thousands of molecules and their interrelationships is impossible. We describe the development and application of a very large-scale causal, computable model of biology which has been used to identify molecular cause and effect hypotheses consistent with data from proteomic experiments. Automated causal analysis can be used to define upstream networks of molecular events which could result in experimentally observed protein changes. It can be used to identify possible causal pathways linking initial experimental perturbations to observed protein or phenotypic changes. Large-scale causal analysis is a powerful new systems-based approach for the interpretation of molecular state measurements in drug discovery.
机译:主题:大规模人类蛋白质互动图;估算采样网络覆盖率(假负率)的统计框架;一种新的测序机179f 1-18从实验数据到机械假设:使用非常大规模的因果模型Dexter Pratt Genstruct Inc,剑桥MA 02140剑桥MA 02140的组织和生物流体的高通量蛋白质组学分析分析蛋白质组学数据样品可以产生数据集,该数据集包括数百次甚至数千蛋白的测量差异。原则上,这种丰富的数据来源可以提供实验中的生物过程的系统级视图,导致描述导致观察到的变化的机制的可测试假设。但通常,数百个观察到推断活性生物网络的集成是一种无法管理的任务,限制了通过注释和调制模式的分类来分类所改变的蛋白质。为了鉴定疾病机制,来自蛋白质组学和系统生物学实验的复合机制和生物标志物需要发展生物学模型。使用精神模型,科学家可以推理大约数百个细胞内存在的分子,但是推理成千上万的分子,并且它们的相互关系是不可能的。我们描述了对来自蛋白质组学实验中的数据一致的分子原因和效果假设的制导和应用,其用于鉴定分子原因和效果假设。自动原因分析可用于定义可能导致实验观察到的蛋白质变化的分子事件的上游网络。它可用于识别将初始实验扰动连接到观察到的蛋白质或表型变化的可能因果途径。大规模因果分析是一种强大的新系统,用于解释药物发现中的分子态测量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号